Cargando…

Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium

BACKGROUND: Turkey is an intermediate hepatitis B virus (HBV) endemic country. However, prevalence among Turkish migrants in Belgium is unknown, especially in those born in Belgium with a foreign-born parent, i.e. second-generation migrants (SGM). AIMS: To evaluate the prevalence of HBV infection an...

Descripción completa

Detalles Bibliográficos
Autores principales: Koc, Özgür M., Kremer, Cécile, Hens, Niel, Bielen, Rob, Busschots, Dana, Van Damme, Pierre, Robaeys, Geert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384618/
https://www.ncbi.nlm.nih.gov/pubmed/32716949
http://dx.doi.org/10.1371/journal.pone.0234740
_version_ 1783563634765463552
author Koc, Özgür M.
Kremer, Cécile
Hens, Niel
Bielen, Rob
Busschots, Dana
Van Damme, Pierre
Robaeys, Geert
author_facet Koc, Özgür M.
Kremer, Cécile
Hens, Niel
Bielen, Rob
Busschots, Dana
Van Damme, Pierre
Robaeys, Geert
author_sort Koc, Özgür M.
collection PubMed
description BACKGROUND: Turkey is an intermediate hepatitis B virus (HBV) endemic country. However, prevalence among Turkish migrants in Belgium is unknown, especially in those born in Belgium with a foreign-born parent, i.e. second-generation migrants (SGM). AIMS: To evaluate the prevalence of HBV infection and associated risk factors in Turkish first-generation migrants (FGM), i.e. foreign-born, and SGM. METHODS: Between September 2017 and May 2019, free outreach testing for hepatitis B surface antigen (HBsAg), hepatitis B core antibodies (anti-HBc), and antibodies against HBsAg was offered to Turkish migrants in Middle-Limburg, Belgium. Face-to-face questionnaire assessed HBV risk factors. HBsAg positive patients were referred and followed up. Turkish SGM were stratified into birth cohort born before and after 1987, since those born after 1987 should be covered by the universal infant vaccination program. RESULTS: A total of 1,081/1,113 (97.1%) Turkish did go for HBV testing. Twenty-six (2.4%) were HBsAg positive; 11/26 were unaware of their status and 10/11 were successfully referred. HBsAg prevalence was 3.0% in FGM and 1.5% in SGM, p = .070. Only one out of seven HBsAg positive SGM was born after 1987. In the multiple generalized estimating equations model, the most important risk factors for anti-HBc positivity were male gender (p = .021), older age (p < .001), FGM (p < .001), low educational level of the mother (p = .003), HBV infected mother (p = .008), HBV infected siblings (p = .002), HBV infected other family member (p = .004), gynaecological examination in Turkey or unsafe male circumcision (p = .032) and dental treatment in Turkey (p = .049). CONCLUSION: Outreach testing was well-accepted and referral to specialist care was generally successful. National HBV screening should be implemented in the Turkish FGM population and might be considered in SGM not covered by primary prevention strategies.
format Online
Article
Text
id pubmed-7384618
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-73846182020-08-05 Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium Koc, Özgür M. Kremer, Cécile Hens, Niel Bielen, Rob Busschots, Dana Van Damme, Pierre Robaeys, Geert PLoS One Research Article BACKGROUND: Turkey is an intermediate hepatitis B virus (HBV) endemic country. However, prevalence among Turkish migrants in Belgium is unknown, especially in those born in Belgium with a foreign-born parent, i.e. second-generation migrants (SGM). AIMS: To evaluate the prevalence of HBV infection and associated risk factors in Turkish first-generation migrants (FGM), i.e. foreign-born, and SGM. METHODS: Between September 2017 and May 2019, free outreach testing for hepatitis B surface antigen (HBsAg), hepatitis B core antibodies (anti-HBc), and antibodies against HBsAg was offered to Turkish migrants in Middle-Limburg, Belgium. Face-to-face questionnaire assessed HBV risk factors. HBsAg positive patients were referred and followed up. Turkish SGM were stratified into birth cohort born before and after 1987, since those born after 1987 should be covered by the universal infant vaccination program. RESULTS: A total of 1,081/1,113 (97.1%) Turkish did go for HBV testing. Twenty-six (2.4%) were HBsAg positive; 11/26 were unaware of their status and 10/11 were successfully referred. HBsAg prevalence was 3.0% in FGM and 1.5% in SGM, p = .070. Only one out of seven HBsAg positive SGM was born after 1987. In the multiple generalized estimating equations model, the most important risk factors for anti-HBc positivity were male gender (p = .021), older age (p < .001), FGM (p < .001), low educational level of the mother (p = .003), HBV infected mother (p = .008), HBV infected siblings (p = .002), HBV infected other family member (p = .004), gynaecological examination in Turkey or unsafe male circumcision (p = .032) and dental treatment in Turkey (p = .049). CONCLUSION: Outreach testing was well-accepted and referral to specialist care was generally successful. National HBV screening should be implemented in the Turkish FGM population and might be considered in SGM not covered by primary prevention strategies. Public Library of Science 2020-07-27 /pmc/articles/PMC7384618/ /pubmed/32716949 http://dx.doi.org/10.1371/journal.pone.0234740 Text en © 2020 Koc et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Koc, Özgür M.
Kremer, Cécile
Hens, Niel
Bielen, Rob
Busschots, Dana
Van Damme, Pierre
Robaeys, Geert
Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium
title Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium
title_full Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium
title_fullStr Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium
title_full_unstemmed Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium
title_short Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium
title_sort early detection of chronic hepatitis b and risk factor assessment in turkish migrants, middle limburg, belgium
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384618/
https://www.ncbi.nlm.nih.gov/pubmed/32716949
http://dx.doi.org/10.1371/journal.pone.0234740
work_keys_str_mv AT kocozgurm earlydetectionofchronichepatitisbandriskfactorassessmentinturkishmigrantsmiddlelimburgbelgium
AT kremercecile earlydetectionofchronichepatitisbandriskfactorassessmentinturkishmigrantsmiddlelimburgbelgium
AT hensniel earlydetectionofchronichepatitisbandriskfactorassessmentinturkishmigrantsmiddlelimburgbelgium
AT bielenrob earlydetectionofchronichepatitisbandriskfactorassessmentinturkishmigrantsmiddlelimburgbelgium
AT busschotsdana earlydetectionofchronichepatitisbandriskfactorassessmentinturkishmigrantsmiddlelimburgbelgium
AT vandammepierre earlydetectionofchronichepatitisbandriskfactorassessmentinturkishmigrantsmiddlelimburgbelgium
AT robaeysgeert earlydetectionofchronichepatitisbandriskfactorassessmentinturkishmigrantsmiddlelimburgbelgium